Loth, Eva
Spooren, Will
Ham, Lindsay M.
Isaac, Maria B.
Auriche-Benichou, Caroline
Banaschewski, Tobias
Baron-Cohen, Simon
Broich, Karl
Bölte, Sven
Bourgeron, Thomas
Charman, Tony
Collier, David
de Andres-Trelles, Fernando
Durston, Sarah
Ecker, Christine
Elferink, Andre
Haberkamp, Marion
Hemmings, Robert
Johnson, Mark H.
Jones, Emily J. H.
Khwaja, Omar S.
Lenton, Sabine
Mason, Luke
Mantua, Valentina
Meyer-Lindenberg, Andreas
Lombardo, Michael V.
O'Dwyer, Laurence
Okamoto, Koichi
Pandina, Gahan J.
Pani, Luca
Persico, Antonio M.
Simonoff, Emily
Tauscher-Wisniewski, Sitra
Llinares-Garcia, Jordi
Vamvakas, Spiros
Williams, Steve
Buitelaar, Jan K.
Murphy, Declan G. M.
Article History
First Online: 31 December 2015
Competing interests
: W.S., K.O., L.M.H. and O.S.K. are employees at F. Hoffmann-La Roche. D.C. and S.T.-W. are employees at Eli Lilly. G.J.P. is an employee at Janssen Research & Development, LLC. A.M.-L. has received consultant fees and travel expenses from Alexza Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Defined Health, Decision Resources, Desitin Arzneimittel, Elsevier, F. Hoffmann-La Roche, Gerson Lehrman Group, Grupo Ferrer, Les Laboratoires Servier, Lilly Deutschland, Lundbeck Foundation, Outcome Sciences, Outcome Europe, PriceSpective and Roche Pharma and has received speaker's fees from Abbott, AstraZeneca, BASF, Bristol-Myers Squibb, GlaxoSmithKline, Janssen-Cilag, Lundbeck, Pfizer Pharma and Servier Deutschland. J.K.B. has been a consultant to, or member of advisory board of, and/or speaker for, Janssen Cilag BV, Eli Lilly, Shire, Lundbeck, Roche and Servier. D.G.M.M. has been a consultant to Roche.